Make us your home page
Instagram

Today’s top headlines delivered to you daily.

(View our Privacy Policy)

Doctors Without Borders says Ebola drug poses 'impossible dilemma'

DAKAR, Senegal — Doctors treating a Sierra Leone physician with Ebola defended their decision not to give him an experimental drug, saying Wednesday they feared it was too risky.

Calling it "an impossible dilemma," Doctors Without Borders explained in detail their decision in response to a New York Times story on the case. It would have been the first time the experimental drug was tried in humans.

The explanation came the same day that another top doctor from Sierra Leone died of the disease, further fueling a debate about how to apportion a limited supply of untested drugs and vaccines and whether they are even effective.

Ebola has killed more than 1,000 people and sickened nearly 2,000 in the current West African outbreak that has also hit Guinea, Liberia and Nigeria. Many of the dead are health workers, who are often working with inadequate supplies and protection.

At the time the experimental treatment was being considered for Dr. Sheik Humarr Khan, his immune system was already starting to produce antibodies suggesting he might recover, Doctors Without Borders said in the statement. Khan was also due to be transferred to a European hospital that would be more capable of handling problems that might arise, the organization said.

The experimental drug, ZMapp, is designed to boost the immune system to help it fight the virus. Since Khan's body was already producing an immune response, the doctors may have feared that any boost would kick it into overdrive.

Doctors Without Borders says Ebola drug poses 'impossible dilemma' 08/13/14 [Last modified: Wednesday, August 13, 2014 9:50pm]
Photo reprints | Article reprints

Copyright: For copyright information, please check with the distributor of this item, Associated Press.
    

Join the discussion: Click to view comments, add yours

Loading...
  1. Jordan Spieth wins British Open (w/ video)

    Golf

    SOUTHPORT, England — Someday, perhaps soon, there will be a plaque at Royal Birkdale for Jordan Spieth, much like the one off the 16th hole that celebrates Arnold Palmer and the 6-iron he slashed out of the rough in 1961 to win the British Open and usher in a new era of golf.

    Matt Kuchar plays out of the bunker on the 18th hole and finishes with bogey for 1-under 69. He had a one-shot lead after 13 holes.
  2. Fennelly: Brutal weekend could be start of something worse for Rays

    The Heater

    ST. PETERSBURG — Well, that was lovely.

    Brad Boxberger suffers his second loss in the three-game series, this time by allowing back-to-back homers in the eighth inning when called on to protect a 5-3 lead. “Just bad pitches,” he says.
  3. Wesley Chapel hockey camp impresses youth players, parents

    Lightning Strikes

    WESLEY CHAPEL — As a 17-year-old Triple-A hockey player, MacCallum Brown regularly plays against elite talent. As a Palm Harbor resident, he often has to travel to face that talent.

  4. Rays claim not to be panicking after third straight brutal loss to Rangers (w/ video)

    The Heater

    ST. PETERSBURG — There was no "here we go again" moment in the dugout as Rougned Odor's two-run homer in the eighth inning arced across Tropicana Field and toward the rightfield seats, even though when it landed, the score was tied and another late-inning Rays lead was blown.

    Rays third baseman Evan Longoria heads back to the dugout after fouling out in the ninth inning with the potential tying run on first.
  5. White House signals acceptance of Russia sanctions bill

    National

    WASHINGTON — The White House indicated Sunday that President Donald Trump would accept new legislation imposing sanctions on Russia and curtailing his authority to lift them on his own, a striking turnaround after a broad revolt in Congress by lawmakers of both parties who distrusted his friendly approach to …

    President Donald Trump’s ability to lift sanctions against Russia would be blocked.